At Pliant Therapeutics, we recognize that our success depends on the excellence of our people. With this in mind, we are highly vested in the recruitment, training and development of our employees.
We are looking for exceptional candidates who are dedicated to our corporate values and are interested in being a part of a team that is committed to developing a pipeline of innovative therapeutics to treat major unmet medical needs.
By harnessing the therapeutic potential of integrin biology and TGF-β modulation, Pliant aims to prevent or even reverse fibrosis to address the needs of many patients. The company also aims to build a patient registry for certain areas of fibrotic disease to both increase understanding of natural disease progression, and fuel biomarker discovery.
Pliant’s co-founders include world-renowned researchers from University of California, San Francisco (UCSF), who bring broad experience in fibrosis biology and small molecule chemistry. Together, the Pliant team is dedicated to translating scientific advances in fibrosis biology into novel therapies for patients in need.

Show more
TypePrivate
HQRedwood City, US
Founded2016
Size (employees)45 (est)+3%
Websitepliantrx.com
Pliant Therapeutics was founded in 2016 and is headquartered in Redwood City, US
Report incorrect company information

Viewing summary data as a guest

Sign up for free to see all data

Key People/Management at Pliant Therapeutics

Bernard Coulie

Bernard Coulie

President and Chief Executive Officer
Katerina Leftheris

Katerina Leftheris

Vice President of Chemistry
Hans Hull

Hans Hull

Chief Business Officer
David Morgans

David Morgans

Vice President of Drug Discovery and Early Development
Patrick Andre

Patrick Andre

Vice President of Biology
Scott Turner

Scott Turner

Vice President Translational Sciences
Show more

Pliant Therapeutics Office Locations

Pliant Therapeutics has an office in Redwood City
Redwood City, US (HQ)
150 700 Saginaw Dr
Show all (1)
Report incorrect company information

Pliant Therapeutics Financials and Metrics

Summary Metrics

Founding Date

2016

Pliant Therapeutics total Funding

$107 m

Pliant Therapeutics latest funding size

$62 m

Time since last funding

6 months ago

Pliant Therapeutics investors

Pliant Therapeutics's latest funding round in July 2018 was reported to be $62 m. In total, Pliant Therapeutics has raised $107 m
View all funding rounds
Report incorrect company information

Pliant Therapeutics News and Updates

Pliant Therapeutics Receives FDA Orphan Drug Designation for Lead Program PLN-74809 in Primary Sclerosing Cholangitis

SOUTH SAN FRANCISCO, Calif., Nov. 20, 2018 /PRNewswire/ -- Pliant Therapeutics, Inc., a biotechnology company focused on discovering, developing and commercializing treatments for fibrotic diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug...
Report incorrect company information

Pliant Therapeutics Blogs

Senior Director, Regulatory Affairs

The post Senior Director, Regulatory Affairs appeared first on Pliant.

Senior Scientist/Associate Director/Director – Toxicology

The post Senior Scientist/Associate Director/Director – Toxicology appeared first on Pliant.

Sr. Research Associate, Medical Chemistry

The post Sr. Research Associate, Medical Chemistry appeared first on Pliant.

Associate Scientist/Scientist Biology

The post Associate Scientist/Scientist Biology appeared first on Pliant.

Scientist/Sr. Scientist Biology – Antibody Engineering

The post Scientist/Sr. Scientist Biology – Antibody Engineering appeared first on Pliant.

Sr. Scientist, DMPK

The post Sr. Scientist, DMPK appeared first on Pliant.
Show more

Pliant Therapeutics Company Life and Culture

Report incorrect company information

Pliant Therapeutics Frequently Asked Questions

  • When was Pliant Therapeutics founded?

    Pliant Therapeutics was founded in 2016.

  • Who are Pliant Therapeutics key executives?

    Pliant Therapeutics's key executives are Bernard Coulie, Katerina Leftheris and Hans Hull.

  • How many employees does Pliant Therapeutics have?

    Pliant Therapeutics has 45 employees.

  • Who are Pliant Therapeutics competitors?

    Competitors of Pliant Therapeutics include E-Qure, Obalon Therapeutics and Oyster Point Pharmaceuticals.

  • Where is Pliant Therapeutics headquarters?

    Pliant Therapeutics headquarters is located at 150 700 Saginaw Dr, Redwood City.

  • Where are Pliant Therapeutics offices?

    Pliant Therapeutics has an office in Redwood City.

  • How many offices does Pliant Therapeutics have?

    Pliant Therapeutics has 1 office.